The No.2 Hospital Of Baoding Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2019
NCT04132570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

THE NO.2 HOSPITAL OF BAODING

Active Ingredients

Drugs in Phase 4 Trials (1)

budesonide (rhinocort) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Rhinitis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1